z-logo
open-access-imgOpen Access
Access Guide to Human Proteinpedia
Author(s) -
Muthusamy Babylakshmi,
Thomas Joji Kurian,
Prasad T.S. Keshava,
Pandey Akhilesh
Publication year - 2013
Publication title -
current protocols in bioinformatics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.535
H-Index - 57
eISSN - 1934-340X
pISSN - 1934-3396
DOI - 10.1002/0471250953.bi0121s41
Subject(s) - human proteome project , human protein atlas , proteome , annotation , human proteins , computer science , upload , computational biology , proteomics , biology , protein expression , bioinformatics , world wide web , genetics , artificial intelligence , gene
Human Proteinpedia (http://www.humanproteinpedia.org) is a publicly available proteome repository for sharing human protein data derived from multiple experimental platforms. It incorporates diverse features of the human proteome including protein-protein interactions, enzyme-substrate relationships, PTMs, subcellular localization, and expression of proteins in various human tissues and cell lines in diverse biological conditions including diseases. Through a publicly distributed annotation system developed especially for proteomic data, investigators across the globe can upload, view, and edit proteomic data even before they are published. Inclusion of information on investigators and laboratories that generated the data, as well as visualization of tandem mass spectra, stained tissue sections, protein/peptide microarrays, fluorescent micrographs, and western blots, ensures quality of proteomic data assimilated in Human Proteinpedia. Many of the protein annotations submitted to Human Proteinpedia have also been made available to the scientific community through Human Protein Reference Database (http://www.hprd.org), another resource developed by our group. In this protocol, we describe how to submit, edit, and retrieve proteomic data in Human Proteinpedia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here